Strauch G, Bricaire H
Nouv Presse Med. 1977 Jan 22;6(3):175-9.
In a group of 16 females and 2 males with hypogonadism and hyperprolactinemia, bromocriptine was found to suppress prolactin (PRL) high levels within one day without further significant lowering during a 3 weeks longitudinal survey. The usually effective dosage was 5 mg per day. On the contrary, sex hormones did not vary initially and increased secondarily only in those patients resuming gonadal activity. The changes were either cyclical or heterogenous when the first cycle was anovulatory. This latter situation could sometimes but not always be attributed to persistent hyperprolactinemia. Menstruation resumed in 11 patients. Persistance of hypogonadism in the remainder could be explained by incomplete PRL reduction in one case and probability of previous hypothalamo-pituitary damage in six. The latter hypothesis was based in part on impaired gonadotropins responses to LH RH which were not modified by the treatment.
在一组16名女性和2名男性的性腺功能减退和高催乳素血症患者中,发现溴隐亭在一天内即可抑制催乳素(PRL)的高水平,并且在为期3周的纵向研究中不会进一步显著降低。通常有效的剂量为每天5毫克。相反,性激素最初没有变化,仅在那些恢复性腺活动的患者中继发增加。当第一个周期无排卵时,变化要么是周期性的,要么是异质性的。后一种情况有时但并非总是可归因于持续性高催乳素血症。11名患者月经恢复。其余患者性腺功能减退持续存在,其中1例可解释为PRL未完全降低,6例可能是既往下丘脑 - 垂体损伤所致。后一种假设部分基于促性腺激素对促黄体生成素释放激素(LH RH)的反应受损,且这种反应未因治疗而改变。